INNOVATIVE THINKING
RIGOROUS APPROACHES
REAL WORLD IMPACT

 

Dr. Jacob M. Benus Presents at the White House’s Office of Science and Technology Policy

IMPAQ founder, Executive Vice President and Director of Research, Dr. Jacob M. Benus discussed the value of low-cost RCTs at an invitation-only White House OSTP Expert Meeting
Washington, DC

|

July 29, 2014

Dr. Jacob M. Benus, Executive Vice President and Director of Research at IMPAQ, recently presented a paper at a White House conference to discuss the value of low-cost Randomized Controlled Trials (RCTs) and their ability to effectively drive social spending.  The conference was hosted by the White House’s Office of Science and Technology Policy (OSTP) and the Coalition for Evidence-Based Policy. As one of four presenters of illustrative examples of Low Cost RCT’s producing policy-important findings, Dr. Benus presented a workforce development project that IMPAQ conducted for the U.S. Department of Labor. 

On Monday, July 28, 2014, in the Eisenhower Executive Office Building, Dr. Benus, along with representatives from the Domestic Policy Council (DPC), Office of Management and Budget (OMB), Federal agencies, Congress, state/local agencies, philanthropic foundations and other leading social policy researchers participated in a conference to explore RCTs as part of the Administration’s Evidence and Innovation Agenda.

“It’s an honor to be invited by the White House and participate in this important conversation,” said Dr. Benus “The RCT method is a powerful tool for researchers and I appreciated the opportunity to explain the value of these research methods.”

When RCTs are conducted under adequate and appropriate conditions, they are considered the most reliable method of assessing the efficiency of programs, practices, and treatments (“interventions”), per evidence standards articulated by the Institute of Education Sciences (IES) and National Science Foundation (NSF), National Academy of Sciences, Congressional Budget Office, U.S. Preventive Services Task Force, Food and Drug Administration, and other notable scientific bodies.

The conference builds on other recent Executive Branch efforts to advance low-cost, rigorous evaluations, described in the 2014 Economic Report of the President and the FY 2015 budget. To learn more about the OSTP’s position on RCTs click here.

About IMPAQ International

IMPAQ International is a public policy research firm that drives value by utilizing innovative thinking and rigorous approaches to improve our client’s policies and programs, delivering meaningful, real world impact. IMPAQ’s mission is to provide exemplary research and consulting services to its clients through the use of impact evaluation studies, applied research, policy analysis, quantitative and qualitative data analysis, and technical assistance.

###